| 000 -LEADER |
|---|
| fixed length control field |
04390nam a22004455i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150235.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
110811s2011 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781441999405 |
|
978-1-4419-9940-5 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC321-580 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
612.8 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
New York, NY : |
| -- |
Springer New York, |
| -- |
2011. |
| 912 ## - |
|---|
| -- |
ZDB-2-SBL |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Farooqui, Akhlaq A. |
| Relator term |
author. |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Lipid Mediators and Their Metabolism in the Brain |
| Medium |
[electronic resource] / |
| Statement of responsibility, etc |
by Akhlaq A. Farooqui. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XXIV, 327p. 103 illus., 63 illus. in color. |
| Other physical details |
online resource. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 1. Metabolism and roles of eicosanoids in brain -- Chapter 2. Recent Developments on the neurochemistry of docosanoids -- Chapter 3. Metabolism, roles, and involvement of lyso-glycerophospholipids in neurological disorders -- Chapter 4. Platelet activating factor in brain: its metabolism, roles and involvement in neurological disorders -- Chapter 5. Cannabinoids in the brain: their metabolism, roles, and involvement in neurological disorders -- Chapter 6. Neurochemical aspects of 4-hydroxynonenal -- Chapter 7. Isoprostanes and other non-enzymic polyunsaturated fatty acid-derived lipid mediators in the brain -- Chapter 8. Ceramide and ceramide 1-phosphate in the brain -- Chapter 9. Sphingosine and sphingosine 1 phosphate in brain -- Chapter 10. Cholesterol and hydroxycholesterol in the brain -- Chapter 11. Perspective and direction for future research on lipid mediators. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Lipid mediators are chemical messengers that are formed in response to cell stimulation or injury from membrane phospholipids, sphingolipid, and cholesterol. They play important roles in internal and external communication and modulate cellular responses such as the growth arrest, differentiation, adhesion, and migration. Lipid mediators of arachidonic acid (ARA) metabolism include prostaglandins, leukotrienes, thromboxanes, lipoxins, whereas lipid mediators of docosahexaenoic acid (DHA) metabolism are resolvins, protectins, neuroprotectins, and maresins. The non-enzymic lipid mediators of ARA and DHA metabolism include isoprostanes, neuroprostanes, isoketals, neuroketals, isofurans, neurofurans, 4-hydroxynonenal, and 4-hydroxyhexanal. Ceramide, ceramide 1-phosphate, sphingosine, and sphingosine 1-phosphate are lipid mediators of sphingolipid metabolism. These mediators are closely associated with apoptotic cell death, cell proliferation, cell migration, and survival. Cholesterol-derived mediators include 24-hydroxycholesterol, 25-hydroxycholesterol, 27-hydroxycholesterol, and 22-hydroxycholesterol. These mediators act as ligands of liver X receptors, transcription factors with key roles in lipid metabolism. Under normal conditions, low levels of lipid mediators are needed for signal transduction, gene expression, and neural cell proliferation and differentiation, but high levels of enzymic and non-enzymic lipid mediators of glycerophospholipid, sphingolipid, and cholesterol metabolism produce neurodegeneration through the induction of oxidative stress, neuroinflammation and synaptic dysfunction. Lipid Mediators and Their Metabolism in the Brain presents readers with cutting edge and comprehensive information not only on the synthesis and degradation of glycerophospholipid-, sphingolipid-, and cholesterol-derived lipid mediators, but also their involvement in neurological disorders. It is hoped that this monograph will be useful not only to postgraduate student and their teachers, but also to research scientists and physicians, who are curious about the generation and roles of lipid mediators in the brain. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Neurosciences. |
|
|---|
| Topical term or geographic name as entry element |
Neurochemistry. |
|
|---|
| Topical term or geographic name as entry element |
Neurology. |
|
|---|
| Topical term or geographic name as entry element |
Biomedicine. |
|
|---|
| Topical term or geographic name as entry element |
Neurosciences. |
|
|---|
| Topical term or geographic name as entry element |
Neurology. |
|
|---|
| Topical term or geographic name as entry element |
Neurochemistry. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9781441999399 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-4419-9940-5 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
